Growth Metrics

Immuron (IMRN) Current Deferred Revenue (2017 - 2023)

Immuron's quarterly Current Deferred Revenue came in at $466645.9 in Q2 2023, down 43.88% year-on-year from $831510.9 in Q2 2022, and down 43.88% quarter-over-quarter from $831510.9 in Q2 2022.

Immuron has reported Current Deferred Revenue for 4 years, with the latest figure at $466645.9 in Q2 2023.

  • For the quarter ending Q2 2023, Current Deferred Revenue fell 43.88% year-over-year to $466645.9; the trailing twelve-month figure through Jun 2023 stood at $466645.9 (down 43.88% YoY), and the FY2023 full-year result was $466645.9, down 43.88% from the prior year.
  • Current Deferred Revenue for Q2 2023 stood at $466645.9, down from $831510.9 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $831510.9 in Q2 2022, with the low at $466645.9 in Q2 2023.
  • Average Current Deferred Revenue over 3 years is $627413.0, with a median of $584082.2 recorded in 2021.
  • Year-over-year, Current Deferred Revenue soared 42.36% in 2022 and plunged 43.88% in 2023.
  • Tracing IMRN's Current Deferred Revenue over 3 years: stood at $584082.2 in 2021, then soared by 42.36% to $831510.9 in 2022, then sank by 43.88% to $466645.9 in 2023.
  • The last three Current Deferred Revenue figures came in at $466645.9 (Q2 2023), $831510.9 (Q2 2022), and $584082.2 (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Immuron 1.27 Bn 1.27 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 466,645.92
Jun 30, 2022 831,510.88
Jun 30, 2021 584,082.20
Dec 31, 2017 14,915.84
Sep 28, 2017 15,094.98
Aug 31, 2017 19,139.00
Jun 30, 2017 14,377.41